Uloric: first new option for gout in more than 40 yearsTakeda Canada will soon be introducing Uloric (febuxostat 80 mg) tablets, the first new drug to be marketed for gout in more than four decades. Much ado about magnesiumMagnesium is one of those under-appreciated, but very interesting supplements. Practice Issues: Adverse reactions - TMP-SMX interaction with ACEIs and ARBs Study measures risk of hyperkalemia after TMP-SMX was prescribed for older patients on either an ACEI or an ARB. Practice Issues: Adverse Reactions - TMP-SMX interaction with ACEIs and ARBs Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are usually well-tolerated drugs. Men and Women's Health 2010: Hypertension 2010 CHEP recommendations for pharmacists. Canadian MD warns against transplant tourism Blood services chief says organization will push for greater domestic organ donation rates Immediate NDM-1 screening needed French expert calls for worldwide screening New anti-rejection strategy excites transplant surgeons Partial transfer of bone marrow cells may trick body into accepting donated organ Kidney stones: new guidelines for medical management The Canadian Urological Association has issued new guidelines for the evaluation and medical management of kidney stone disease. New guidelines highlight BPH diagnosis and management The Canadian Urological Association has issued consensus guidelines on the diagnosis and management of benign prostatic hyperplasia. First Previous 64 65 66 67 68 Next Last
